Product Details

Zaxine

Rifaximin
550 mg
Tablet


DIN/PIN/NPN

02410702

Manufacturer

Salix Pharmaceuticals Inc.

Formulary Listing Date

2016-06-29  

Unit Price

8.3030

Amount MOH Pays

8.3030

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

A07AA11

Interchangeable Products

NO  

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
475 Indefinite

For reducing the risk of overt hepatic encephalopathy (HE) recurrence (i.e., 2 or more episodes) in patients who are unable to achieve adequate control of HE recurrence with maximal tolerated dose of lactulose alone. Rifaximin should be used in combination with a maximal tolerated dose of lactulose. For patients not maintained on lactulose, the nature of the patient's intolerance to lactulose should be documented.

 

EAP Criteria

NO

Product Monograph

View Monograph